Concerned About Memory Loss?
Test for Dementia with a Simple Blood Test
This non-invasive test supports early Dementia diagnosis with over 90% accuracy. No referral needed, no NHS waiting lists, and results in 15 working days.
03
Non-Invasive
Only a blood sample is needed, making it easier, quicker and more comfortable to get tested. Until now highly-invasive Lumbar Puncture tests or PET scans have been required.
04
No Waiting Lists & Fast Results
Don't wait months just for a referral from the NHS. Receive a detailed risk assessment within 15 working days. The risk assessment can be sent directly to your doctor and you can make an appointment with them to discuss the results and any appropriate next steps.
02
High Accuracy
Achieves 90% accuracy in detecting amyloid pathology, giving you and your healthcare provider confidence in the results, aligning with standards set by The Global Initiative.
01
Cost-Effective
At £695, LucentAD Complete is a fraction of the cost of traditional diagnostic methods. PET Scans and Lumbar Punctures usually cost more than £3,000 per test.
Greater Access to Early Detection
LucentAD Complete is a state-of-the-art blood test that provides an accurate picture of Dementia risk through a simple blood sample. By analyzing specific biomarkers linked to Dementia disease, including p-Tau 217, the test offers over 90% diagnostic accuracy - all without the need for invasive or costly procedures like lumbar punctures or PET imaging.
"Having access to this sophisticated, non-invasive blood test is a game-changer for early Alzheimer’s diagnosis in the UK. By simplifying diagnostics, we’re helping more patients access critical care sooner, especially as new therapies for early-stage Alzheimer’s are becoming available."
Dr Karan Jutlla
Head of the Centre for Applied and Inclusive Health Research,
University of Wolverhampton
Plan with Confidence
Knowing earlier allows you to take important steps in planning for the future. By arranging care preferences, securing legal documents, drafting a will and appointing a power of attorney, you ensure your wishes are respected and loved ones supported.
Proactive steps provide peace of mind, empowering you to focus on living well now.
Reassurance in a Clear Result
A test result that rules out Dementia offers reassurance and clarity. By ruling out Dementia, you and your healthcare provider can focus on exploring other potential causes of symptoms, ensuring you receive the right care and treatment. For many, a negative result also provides relief, removing the uncertainty and worry, allowing them to move forward with confidence. Please note, Advance Tests is not affiliated with these medications or their manufacturers.
Explore Treatment Options
The MHRA has recently approved two promising new drugs, Lecanemab and Donanemab, both of which can delay symptom onset and enhance quality of life. Although not currently available through the NHS, they may be accessed privately.
Please note, Advance Tests is not affiliated with these medications or their manufacturers.
Adopt Lifestyle Changes
Extensive research has shown that lifestyle changes can significantly impact the progression of Dementia. By knowing early, your doctor and caregivers can recommend personalised lifestyle adjustments that can enhance your quality of life and potentially extend it.
Get Tested.
Take Control.
Seeking to understand the likelihood of Dementia can feel overwhelming. However, knowing and understanding key bio-markers can empower you to take control of your future, offering clarity, access to early treatment options, and the ability to plan ahead with confidence.
It can also stop the uncertainty of not knowing, and for many allows them to rule out Dementia at this time.
How to Book a Test?
3. Visit our Clinic
Come in for a quick and straightforward blood draw at one of our testing locations.
4. Receive Results
Within 15 working days, your results will be shared with you and/or your healthcare provider through a secure online portal.
2. Or Order by Doctor
Your healthcare provider can also refer you for testing through our online system.
1. Book Online
Schedule your appointment below:
ABOUT US
Advance Tests collaborates with globally trusted biotech innovators, adopting their breakthrough diagnostic technologies once they meet stringent accreditation and compliance standards in leading healthcare markets.
This enables Advance Tests to rapidly introduce proven tests to the UK, targeting critical patient backlogs and supporting those at high risk due to genetic or symptomatic factors.
Our first testing location is conveniently situated at St Thomas Street, London Bridge Station, directly adjacent to Guy’s Hospital. Additional clinics will soon be available in major cities across the UK to make this test accessible nationwide.
If the London clinic is not suitable for you, please tell us here where you would like our next clinic to be.
Where to Find Us
Accessible
While not yet available on the NHS, the Simoa p-Tau 217 test (the core of LucentAD Complete) was granted FDA Breakthrough Device Designation in March 2024.
Accurate
With over 90% accuracy, the only plasma biomarker for diagnosing amyloid pathology which meets the Dementia Association strict criteria.
Committed to Research
Advance Tests are working with the Centre for Applied and Inclusive Health Research at the University of Wolverhampton to help advance understanding of Dementia.
Why Choose Advance Tests?
If you are a medical professional and would like to refer your patients to Advance Tests, please get in touch - we'd love to support your patients in any way we can.
Medical Professional?
Social Media
Contact
This website was made by Add People